These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 25830370)

  • 21. Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation.
    Rawat MK; Jain A; Singh S
    J Pharm Sci; 2011 Jun; 100(6):2366-78. PubMed ID: 21491449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation, Characterization, and Evaluation of Eudragit-Coated Saxagliptin Nanoparticles Using 3 Factorial Design Modules.
    Alhamhoom Y; Ravi G; Osmani RAM; Hani U; Prakash GM
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364338
    [No Abstract]   [Full Text] [Related]  

  • 23. Enhanced bioavailability and antihypertensive activity of nisoldipine loaded nanoemulsion: optimization, cytotoxicity and uptake across Caco-2 cell line, pharmacokinetic and pharmacodynamic studies.
    Mundada VP; Patel MH; Mundada PK; Sawant KK
    Drug Dev Ind Pharm; 2020 Mar; 46(3):376-387. PubMed ID: 32031412
    [No Abstract]   [Full Text] [Related]  

  • 24. Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.
    Abul Kalam M; Sultana Y; Ali A; Aqil M; Mishra AK; Aljuffali IA; Alshamsan A
    J Biomed Mater Res A; 2013 Jun; 101(6):1813-27. PubMed ID: 23255511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development, Optimization, and Evaluation of Carvedilol-Loaded Solid Lipid Nanoparticles for Intranasal Drug Delivery.
    Aboud HM; El Komy MH; Ali AA; El Menshawe SF; Abd Elbary A
    AAPS PharmSciTech; 2016 Dec; 17(6):1353-1365. PubMed ID: 26743643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of particle size on oral bioavailability of darunavir-loaded solid lipid nanoparticles.
    Desai J; Thakkar H
    J Microencapsul; 2016 Nov; 33(7):669-678. PubMed ID: 27701988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Solid Lipid Nanocarrier of Glibenclamide: A Factorial Design Approach with Response Surface Methodology.
    Pandey S; Patel P; Gupta A
    Curr Pharm Des; 2018; 24(16):1811-1820. PubMed ID: 29788881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and evaluation of glyceryl behenate based solid lipid nanoparticles (SLNs) using hot self-nanoemulsification (SNE) technique.
    Negi JS; Chattopadhyay P; Sharma AK; Ram V
    Arch Pharm Res; 2014 Mar; 37(3):361-70. PubMed ID: 23695866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis.
    Pradhan M; Singh D; Singh MR
    Chem Phys Lipids; 2015 Feb; 186():9-16. PubMed ID: 25447290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced Oral Bioavailability of Felodipine from Solid Lipid Nanoparticles Prepared Through Effervescent Dispersion Technique.
    He Y; Zhan C; Pi C; Zuo Y; Yang S; Hu M; Bai Y; Zhao L; Wei Y
    AAPS PharmSciTech; 2020 Jun; 21(5):170. PubMed ID: 32529303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid lipid nanoparticles and nanosuspension of adefovir dipivoxil for bioavailability improvement: formulation, characterization, pharmacokinetic and biodistribution studies.
    Dodiya S; Chavhan S; Korde A; Sawant KK
    Drug Dev Ind Pharm; 2013 May; 39(5):733-43. PubMed ID: 22690834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced Oral Absorption of All-trans Retinoic Acid upon Encapsulation in Solid Lipid Nanoparticles.
    Kumar M; Sharma G; Singla D; Singh S; Kakkar V; Gulati JS; Kaur IP
    Pharm Nanotechnol; 2020; 8(6):495-510. PubMed ID: 33115399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The design of naproxen solid lipid nanoparticles to target skin layers.
    Akbari J; Saeedi M; Morteza-Semnani K; Rostamkalaei SS; Asadi M; Asare-Addo K; Nokhodchi A
    Colloids Surf B Biointerfaces; 2016 Sep; 145():626-633. PubMed ID: 27288817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats.
    Ansari MJ; Anwer MK; Jamil S; Al-Shdefat R; Ali BE; Ahmad MM; Ansari MN
    Drug Deliv; 2016 Jul; 23(6):1972-9. PubMed ID: 26017100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Capecitabine lipid nanoparticles for anti-colon cancer activity in 1,2-dimethylhydrazine-induced colon cancer: preparation, cytotoxic, pharmacokinetic, and pathological evaluation.
    Dudhipala N; Puchchakayala G
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1572-1582. PubMed ID: 29493289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
    Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
    Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and Optimization of Meropenem-Loaded Solid Lipid Nanoparticles: In Vitro Evaluation and Molecular Modeling.
    Mhango EKG; Kalhapure RS; Jadhav M; Sonawane SJ; Mocktar C; Vepuri S; Soliman M; Govender T
    AAPS PharmSciTech; 2017 Aug; 18(6):2011-2025. PubMed ID: 27933586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel monolithic controlled delivery system of resveratrol for enhanced hepatoprotection: nanoformulation development, pharmacokinetics and pharmacodynamics.
    Singh A; Ahmad I; Ahmad S; Iqbal Z; Ahmad FJ
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1524-36. PubMed ID: 26902951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.